You just read:

dMed Biopharmaceutical, a next generation CRO, announced the opening of its US Regulatory Affairs office in Washington DC to build a bridge for affordable innovative drugs for US patients

News provided by

dMed Biopharmaceutical Co., Ltd.

Jun 19, 2019, 18:03 ET